Thyrotropin-releasing hormone, chlorpromazine and L-dopa or bromocriptin tests in Cushing's syndrome due to adrenal hyperplasia and adrenal adenoma.
D000236:Adenoma / Q000150:complications*; D000293:Adolescent; D000310:Adrenal Gland Neoplasms / Q000150:complications*; D000311:Adrenal Glands / Q000473:pathology*; D000328:Adult; D001971:Bromocriptine; D002746:Chlorpromazine; D003480:Cushing Syndrome / Q000209:etiology*; D005260:Female; D006801:Humans; D006965:Hyperplasia; D007980:Levodopa; D011388:Prolactin / Q000097:blood; D013973:Thyrotropin-Releasing Hormone
D001971:Bromocriptine; D007980:Levodopa; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D002746:Chlorpromazine